Gollasch Benjamin, Wischnewski Oskar, Rudolph Birgit, Anistan Yoland-Marie, Luft Friedrich C, Gollasch Maik
Experimental and Clinical Research Center (ECRC), Berlin, Germany.
HELIOS Klinikum Berlin-Buch, Medical Clinic for Cardiology, Nephrology and Pneumology, Berlin, Germany.
Case Rep Nephrol Dial. 2018 May 16;8(2):90-97. doi: 10.1159/000489087. eCollection 2018 May-Aug.
We present a 42-year-old man with a BMI of 32, who was referred because of proteinuria and decreased renal function. We were impressed by his markedly muscular physique. A renal biopsy was performed, which showed focal segmental glomerular sclerosis (FSGS). Is this patient merely an obese person with FSGS or is something else going on here? We performed extensive clinical and laboratory examinations, genetic testing, and anthropometric data monitoring over time. We transferred our methodology for routine FSGS mutation screening (Sanger sequencing) to the Ion Torrent PGM platform with a new custom-targeted NGS gene panel (Ion Ampliseq FSGS panel) and tested the performance of the system in two cohorts of patients with FSGS. We discuss FSGS in bodybuilders, including possible mechanisms, and review the literature.
我们报告一名42岁男性,体重指数(BMI)为32,因蛋白尿和肾功能减退前来就诊。他显著的肌肉体格给我们留下了深刻印象。进行了肾活检,结果显示为局灶节段性肾小球硬化(FSGS)。该患者仅仅是一名患有FSGS的肥胖者,还是另有其他情况?我们进行了广泛的临床和实验室检查、基因检测,并长期监测人体测量数据。我们将常规FSGS突变筛查方法(桑格测序)转移至Ion Torrent PGM平台,采用新的定制靶向二代测序(NGS)基因panel(Ion Ampliseq FSGS panel),并在两组FSGS患者中测试了该系统的性能。我们讨论了健美运动员中的FSGS,包括可能的机制,并对文献进行了综述。